Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. Biocartis Group NV
  6. Summary
    BCART   BE0974281132

BIOCARTIS GROUP NV

(BCART)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Real-time Quote. Real-time Euronext Bruxelles
06/07/2021 06/08/2021 06/09/2021 06/10/2021 06/11/2021 Date
4.04(c) 4(c) 4.14(c) 4.13(c) 4.14(c) Last
95 279 41 903 78 941 44 274 37 334 Volume
+1.76% -0.99% +3.50% -0.24% +0.24% Change
More quotes
Financials
Sales 2021 58,2 M 70,4 M 70,4 M
Net income 2021 -61,0 M -73,8 M -73,8 M
Net Debt 2021 88,0 M 106 M 106 M
P/E ratio 2021 -
Yield 2021 -
Sales 2022 82,3 M 99,6 M 99,6 M
Net income 2022 -47,0 M -56,9 M -56,9 M
Net Debt 2022 135 M 163 M 163 M
P/E ratio 2022 -
Yield 2022 -
Capitalization 238 M 288 M 288 M
EV / Sales 2021 5,61x
EV / Sales 2022 4,54x
Nbr of Employees 484
Free-Float 83,6%
More Financials
Company
Biocartis Group NV specializes in the development of molecular diagnostic systems. Especially for the treatment of cancers and infectious diseases, the products ensure the analysis of biomolecules associated with risk factors, early detection, treatment selection and monitoring of disease. The group has the Idylla system to deliver results within a period of between 35 to 150 minutes. Net sales by source of income... 
More about the company
Ratings of Biocartis Group NV
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about BIOCARTIS GROUP NV
06/04BIOCARTISá : Results of the Extraordinary Shareholders' Meeting held on 4 June 2..
PU
06/04PRESS RELEASE BIOCARTIS GROUP NV : Results of the Extraordinary Shareholders' Me..
AQ
06/04BIOCARTIS GROUP NVá : Proxy Statments
CO
05/17PRESS RELEASE BIOCARTIS GROUP NV : Invitation to the Extraordinary Shareholders'..
AQ
05/17BIOCARTIS GROUP NVá : Extraordinary general shareholder meeting
CO
05/14BIOCARTISá : Results of the Shareholders' Meetings held on 14 May 2021
PU
05/14PRESS RELEASE BIOCARTIS GROUP NV : Results of the Shareholders' Meetings held on..
AQ
05/14BIOCARTIS GROUP NVá : Proxy Statments
CO
05/11BIOCARTISá : Receives EUR 1.4m Grant to Support Development of New Idylla™..
PU
05/11PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Receives EUR 1.4m Grant to Support ..
AQ
05/04ASTRAZENECAá : Biocartis Expand Partnership To Make EGFR Testing Available For L..
MT
05/04BIOCARTISá : Announces New Collaboration with AstraZeneca to Expand Availability..
PU
05/04PRESS NEWS BIOCARTIS GROUP NV : Biocartis Announces New Collaboration with Astra..
AQ
04/22BIOCARTISá : Q1 2021 business update
PU
04/22PRESS RELEASE BIOCARTIS GROUP NV : Biocartis and SkylineDx Sign Collaboration to..
AQ
More news
News in other languages on BIOCARTIS GROUP NV
06/09Brussel vlak van start
06/07BRUSSELS STOCK EXCHANGE : Bel20 herpakt zich tegen sluit
06/04BIOCARTISá : Resultaten van de buitengewone aandeelhoudersvergadering gehouden o..
06/04Voorzichtig optimisme in Brussel
06/04Afwachtende houding in Brussel
More news
Chart BIOCARTIS GROUP NV
Duration : Period :
Biocartis Group NV Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIOCARTIS GROUP NV
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Average target price 7,33 €
Last Close Price 4,14 €
Spread / Highest target 93,2%
Spread / Average Target 77,1%
Spread / Lowest Target 57,0%
Managers and Directors
NameTitle
Herman Verrelst Chief Executive Officer & Executive Director
Jean-Marc Roelandt Chief Financial Officer
Christian Reinaudo Independent Chairman
Benoit Devogelaere Chief Technology Officer
Piet Houwen Chief Operating Officer
Sector and Competitors
1st jan.Capitalization (M$)
BIOCARTIS GROUP NV-10.97%288
NOVOCURE LIMITED24.99%22 366
MASIMO CORPORATION-17.28%12 210
PENUMBRA, INC.65.59%10 572
GETINGE AB60.65%10 098
ASAHI INTECC CO., LTD.-29.96%6 347